The Egyptian Journal of Chest Diseases and Tuberculosis 2018, 67:287-294 larger size and better quality of the obtained specimens' excellent tissue preservation than that can be used during conventional fiberoptic FB.
Background
Lung cancer is considered to be one of the most common causes of death among patients with confirmed cancer all over the world. Bronchoscopic diagnosis with ordinary forceps biopsy (FB) is applied primarily for those with endobronchial mass or with suspected visible abnormalities. The small-sized sample is the main limitation for the diagnostic yield by this procedure. Cryoprobe that is mainly used for the cryotherapy purpose has been involved and used nowadays for adequate diagnostic biopsy in patients with suspected endobronchial tumors or lesions. Aim The aim was to compare the flexible cryoprobe with conventional FB regarding diagnostic yield, and to show the feasibility, safety, and possible complications in patients with endobronchial tumor lesions. Patients and methods A total of 40 patients with endoscopically visible lesions were randomized into two groups: group I included 20 patients in whom biopsies were carried out using FB (two samples) and group II included 20 patients in whom biopsies were carried out using cryobiopsy (CB) (one sample).
Results
There was higher significant diagnostic yield of CB as regards the diameter size, finally diagnosed type of lung cancer and that was diagnosed from the first time bronchoscopy or after redobrochoscopy than FB. Bleeding was the only detected complication during both procedures, but there were no statistically significant difference among both techniques as regards bleeding during procedure, need for hamostatics during the procedure, hemoptysis postprocedure or need for hemostatics postprocedure. Conclusion Endobronchial CB is a safe, successful, and confident technique with superior diagnostic yield compared with ordinary conventional FB mainly because of the Introduction Lung cancer is considered as one of the most common causes of death among patients with confirmed cancer all over the world. Histopathological cell-type diagnosis and staging of primary lung cancer are essential and mandatory to develop a proper adequate treatment strategy that could affect the prognosis [1] . Forceps biopsy (FB) is still the diagnostic method of choice in cases of endobronchial lesions to obtain a histopathological sample for proper diagnosis and management.
Histopathological cell diagnosis of lung cancer is widely achieved via invasive techniques including mucosal FB, washing, or brushing. Transthoracic needle aspiration or biopsy even with the recently advanced radiological techniques such as ultrasound or computed tomography (CT) is still invasive [2] . The diagnostic accuracy is variable according to the size and accessibility related to the location of the target lesions [3] . The diagnostic utility or yield is reduced by the small-sized sample, which may result in several problems including a limited yield of the obtained sections per the examined specimen along with the resultant mechanical damage occurring during the biopsy specimen procedure causing difficult interpretation of the involved anatomic structures and histopathologic changes. Larger, more sizable biopsy samples are required for increasing the diagnosis quality and yield using this diagnostic procedure [4] . To overcome this limitation and to increase the diagnostic yield, cryoprobe FB technique is suspected to obtain more sizable histopathologic samples with less mechanical damage. This procedure is mainly and primarily used for cryoextraction of airway narrowing and stenosis by malignant lesions and was also involved as an alternative technique for endobronchial mass debulking which is immediately effective [5] . After freezing using the cryorecanalization technique, the endobronchial mass is then pulled with the probe through the affected airways. By this technique, more sizable histopathologic specimens could be adequately taken from suspected endobronchial masses [6] . A novel cryoprobe with greater stability to traction technique and larger surface area than the ordinary cryotherapy probe must be used for endobronchial recanalization procedure including biopsies. This technique has been included for endobronchial lesion biopsy. Because of well-preserved extraordinarily large tissue samples (larger in size with less mechanical damage and mostly consists of vital tumor tissue) from cryorecanalization procedures, this technique has been transferred and used for the biopsy of endobronchial lesions [7] . So, the present study aimed to compare flexible cryoprobe with conventional FB regarding the diagnostic yield, showing the feasibility, safety, and possible complications in patients with endobronchial tumor lesions.
Patients and methods
This study was performed between May 2016 and June 2017 in the Bronchoscopy Unit of Chest Hospital of Military Kobri Al-Kobba Medical Complex. This study was approved by medical ethics committee. It was a randomized, prospective controlled comparative study in which 40 patients with endoscopically visible lesion were randomized into two groups: group I included 20 patients in whom biopsies were carried out using FB (two samples) and group II included 20 patients in whom biopsies were carried out using cryobiopsy (CB) (one sample). Signed informed consent form were taken from all the included patients. Inclusion criteria: patients with suspected endobronchial malignant lesions, based on clinical diagnosis (full history and clinical examination), radiological imaging [chest radiography (CXR) and enhanced CT chest], and exophytic endobronchial tumor (endoscopically visible lesion). Included patients must have sufficient respiratory function and oxygen saturation greater than 90% with 2 l of supplementary oxygen and should be vitally stable (pulse rate, blood pressure, and temperature). Exclusion criteria: patients with previous cancerspecific treatment and previous endobronchial diagnostic technique. Patients undergoing fiberoptic bronchoscopy for other causes apart from suspicious malignancy, presence of contraindications to bronchoscopy absolute or relative.
All included patients were subjected to the followings.
Detailed medical history taking
Initial evaluation before the procedure with special concern to the following.
Clinical examination: with special stress on the general condition, comorbidities,vital signs, oxygen saturation on room air (ensuring that there was no contraindication to the planned procedure), and local assessment.
Baseline laboratory investigations: complete blood picture, erythrocytic sedimentation rate, renal and hepatic profiles, coagulation parameters including prothrombin time, international normalization ratio, and partial thromboplastin time.
Arterial blood gases
Baseline imaging studies: plain CXR, posteroanterior view CT chest without contrast for all patients, CT with contrast.
During bronchoscopy: monitoring vital signs throughout the procedure and recording and management of any complications during the procedure (e.g. active bleeding, pneumothorax, etc.).
After finishing the procedure: close monitoring of vital signs and oxygen saturation, recording and management of any complications postbronchoscopic (e.g. hemoptysis, pneumothorax, nausea, vomiting, thrombotic events, etc.), assessing the need for admission to the ward or the ICU and recording the duration of admission postbronchoscopy, planning for follow-up visit after 1 week or earlier for recognition of histopathological examination results.
For histopathology: all samples were fixed in 10% formalin for at least 24 h before pathological analysis. Using centimeters, biopsies were measured in the largest diameter prior to sectioning for microscopic evaluation.
The flexible bronchoscope: the flexible bronchoscope used was Pentax EB-1830T3 video bronchoscope (Olympus Company, Japan, Tokyo) 6.0 mm insertion tube, 2.6 mm working channel, 60 cm working length. It was inserted transnasally or transorally while the patient was lying supine with the evaluation of the tracheobronchial tree and recording site of visible endobronchial lesion.
The forceps: two biopsies were taken conventionally (using a reusable fenestrated forceps FB-21C or FB-52C-1; Olympus Corp, Hamburg, Germany).
The cryoprobe: cryoprobe was used with carbon dioxide as the cryogen. The temperature of the probe tip was approximately −89°C (Erbokryo; ERBE Medizintechnik GmbH, Tuebingen, Germany). The flexible cryoprobe was placed onto the endobronchial lesion, and the freezing process was started for 3-5 s or until the ice front reached the bronchial wall. The probe was pulled out en bloc together with the bronchoscope and the frozen tissue sample on the probe's tip. The tissue was then released from the probe's tip by thawing in a sterile 0.9% sodium chloride water bath and was placed in formalin.
Statistical analysis
Data were expressed as mean±SD, median, range, or percentages. Categorical data were analyzed with the chi-square test to compare between two groups as regards the qualitative data. Quantitative data were compared among two independent groups, which were compared using independent t-test. Among the same group, correlation was estimated between two quantitative parameters using Spearman's correlation coefficients. A statistically significant difference was defined as P values of less than 0.05 and less than 0.01 were defined as a highly significant value. On the other hand, a P value of greater than 0.05 is a nonsignificant value. All statistical analyses were assessed using the statistical software SPSS version 20.0, package for Windows (IBM Corporation,Armonk, New York, USA).
Results
There was a highly significant difference between diagnostic yield of endobronchial CB and endobronchial biopsy by forceps as regards the range of tissue biopsy (diameter size), finally diagnosed type of lung cancer and that was diagnosed from the first time bronchoscopy or after redobronchoscopy which were higher among endobronchial CB included group of patients (P=0.000 for each). Also, there was significant histopathologically diagnosed biopsies performed by cryoprobe rather than those by FB (P=0.021) ( Table 1 ).
The only detected complication during both procedures was bleeding, but it was not significant among both groups of patients who underwent either CB or forceps procedures. So, there was no statistically significant difference between both procedures as regards bleeding during procedure, need for hamostatics during procedure, hemoptysis postprocedure or need for hemostatics postprocedure ( Table 2) .
There was a significant statistical higher diagnostic yield for CB than forceps. CB was diagnostic among the included 20 (100%) patients where forceps was only diagnostic in 17 of the included 20 patients (85%). So, 15.0% of cases were not diagnosed after two times of bronchoscopy by forceps tissue biopsy intake due to the insufficient size of superficial mucosal tissue. Different pathological types of malignant lung masses in the study are shown in Table 3 .
All included patients (n=40) were men with the mean age±SD of 60.25±6.48, ranging between 46 and 74 years old. Most of them were smokers 18 (45.0%), whereas 16 (40.0%) were ex-smokers. On the other hand; six (15.0%) were nonsmokers (Table 4 ). (Table 5 ).
Discussion
Lung cancer is considered to be one of the most common causes of death among patients with confirmed cancer all over the world. Histopathological cell-type diagnosis and staging of primary lung cancer is essential and mandatory to develop a proper adequate treatment strategy that could affect the prognosis [1] . FB is still the diagnostic method of choice in cases of endobronchial lesions to obtain a histopathological sample for proper diagnosis and management. Histopathological cell diagnosis of lung cancer is widely achieved via invasive techniques including mucosal FB, washing, or brushing. Transthoracic needle aspiration or biopsy even with the recently advanced radiological techniques such as ultrasound or CT is still invasive [2] . The diagnostic accuracy is variable according to the size and accessibility related to the location of the target lesions [3] . Fiberoptic video bronchoscope nowadays allows high-definition images of the bronchial tree. The procedure has become not only a simple diagnostic, but also a therapeutic procedure one. First, endobronchial cryotherapy and biopsy using flexible bronchoscope were used for rapid urgent relief of obstruction in patients with endobronchial obstruction [8] . This procedure with endobronchial CB has progressed and expanded because several studies reported its valuable effectiveness and safety, because the use of the cryotherapy probe provides sizable endobronchial tumor sampling, producing adequate well-preserved tissue making it superior in quality to that obtained by flexible FB alone [9] . The present study aimed to compare flexible cryoprobes with conventional FB regarding diagnostic yield and possible complications in patients with suspected endobronchial carcinoma. To fulfill this aim, 40 male patients with suspected endobronchial malignant lesions based on clinical diagnosis, CXR, and enhanced CT chest were randomized equally into two groups. Group 1 included 20 patients in whom two biopsies were carried out using the FB technique and group 2 included 20 patients in whom one biopsy was carried out using cryoprobe in the bronchoscopy unit of the Chest Hospital of Military Kobri Al-Kobba Medical Complex. All samples were fixed in 10% formalin for at least 24 h before pathological analysis. Using centimeters, biopsies were measured in the largest diameter prior to sectioning for microscopic evaluation. Data were recruited from the Outpatient Clinic and Inpatient Department at Chest Hospital of Military Kobri Al-Kobba Medical Complex during the period from May 2016 to June 2017. In the current study; there was a highly significant diagnostic yield of bronchoscopic CB technique compared with conventional bronchoscopic FB in cases of bronchogenic carcinoma. As recorded, all 40 (100%) patients in group 2 for whom biopsies were carried out using bronchoscopic cryoprobe were histopathologically diagnosed from the first procedure with no need for redobronchoscopy. On the other hand; 11 (55.0%) patients included in group 1 were diagnosed from the first bronchoscopic forceps procedure, six (30.0%) were diagnosed after second trial whereas the remaining three (15%) failed to be diagnosed despite two different subsequent bronchoscopic FB trials. Therefore histopathological reports usually recommended a larger tissue biopsy size as they were tiny or insufficient for proper diagnosis. These results came in accordance with those of Zafer et al. [10] who studied 41 patients with interventional bronchoscopy where three FBs and one cryoprobe biopsy were obtained from every patient. Histopathological examination and interpretations of the biopsies were performed by one expert pathologist and found that FB was capable for diagnosing 32 (78%) patients, whereas CB was successful to diagnose 38 (92.7%) patients (P=0.031), thus concluding that cryobiopsies were more accurate with higher diagnostic yield than forceps biopsies for endobronchial tumor mass. These were also matched with those of Hetzel et al. [11] and El-Dahdouh et al. [12] studies in which a total of 593 patients randomly underwent diagnostic fiberoptic bronchoscopy for the diagnosis of suspected endobronchial malignancy; 281 underwent endobronchial biopsies using forceps and a flexible cryoprobe was used to perform biopsies in the remaining 282 patients. A definite diagnosis was confirmed among 85.1% of patients for whom FB was performed and in 95.0% of patients for whom CB (P<0.001) was the selected procedure, suggesting that endobronchial CB has superior diagnostic yield compared with conventional FB. Govert et al. [13] found somewhat lower diagnostic yield and sensitivity of FB in their study (in which only two specimens were obtained from every lesion, according to their study protocol) compared with other studies that used multiple sampling (three to four specimens), thus explaining their lower yield. Gellert et al. [6] did not confirm their explanation as they stated that even with multiple sampling, diagnostic yield may slightly increase with only minimal differences and showed that at least five biopsy specimens were required to assume a greater than 90% probability of obtaining at least one positive sample and also concluded that the diagnostic yield of CB was significantly higher compared with FB. There was highly significant statistical difference between endobronchial CB and endobronchial biopsy by forceps in the present study as regards the mean range of tissue biopsy (diameter size). While the largest diameter of tissue biopsy (in cm) in cases of CB was in range of 0.9-1.6 cm with a mean of 1.18±0.20, it was only in the range of 0.2-0.5 with a mean of 0.36 ±0.09 among the studied patients using FB (P<0.001). These results came in accordance with those of Zafer et al. [10] in which the mean diameters of samples taken with FB and CB were 0.2 and 0.8 cm, respectively (P<0.001). The results were also in accordance with the study by Hetzel et al. [11] which proved the total area of each tissue sample taken by CB to be twice as large as FB, with the resultant higher quality of cryobiopsies due to the statistically significant higher artifact-free area per slide in the CB group compared with the forceps group (9.6 vs. 3.6 mm 2 ). Also El-Dahdouh et al. [12] and Rubio et al. [14] confirmed the present results as they found that the mean size of the material obtained by CB was significantly larger compared with FB where they were 1.4 versus 0.5 and 0.696 versus 0.0373 cm, respectively, in their studies. Tamboli [15] results were convenient with the present study as he found that the largest sample size taken via FB never exceeded 0.5 cm in diameter and also concluded that the superior larger biopsy specimen taken through. the CB procedure was one of the major reasons that led to its higher diagnostic yield and success among the studied population of patients.
Hamidreza et al. [16] and Aleva et al. [17] also supported the present results and stated that it is without doubt that the bigger the FB, the more sizable is the obtained tissue specimens, and in turn provides better quality and in turn better results. But this is not true because even if specimens were larger, the more is the mechanical damage that significantly influenced the histopathological results. So, they found that tissue biopsy using the cryo technique provides specimens with better quality besides being more sizable. Least mechanical damage provided by CB preserves tissue structure, a fact that may be explained by only gentle touching of the tumor mass required during this procedure. On the other hand, FB needs traumatic squeezing of the tumor tissue and also clot formation produced by hemostatic effects of −89°applied to the tissue during the cryo procedure, resulting in an artifact-free tissue sample. These factors result in larger tumor tissue per sample and in turn better histopathological evaluation.
Bleeding was the only detected complication during both procedures in the present study. Bleeding severity was defined as minimal if less than 30 ml, moderate if between 30 and 100 ml, and severe if greater than 100 ml. But it was not significant among both the groups of patients who underwent either CB or forceps procedures. So, no statistically significant difference between both procedures as regards bleeding severity, bleeding during procedure, need for hemostatics during the procedure, hemoptysis postprocedure, or need for hemostatics postprocedure. All patients included in the study in both groups were vitally and generally stable at the end of the procedure and there was no indication for ICU observation or bronchospasm, routine CXR after bronchoscopy for all the cases did not detect pneumothorax for any patient. Follow-up of all 40 cases reported no deaths after bronchoscopy. Arrest on table was not recorded as well. This was in agreement with Zafer et al. [10] and El-Dahdouh et al. [12] who also recorded that the only recorded complication among both procedures was hemorrhage, but the incidence of hemorrhage was not significantly different among both biopsy procedures (P>0.05) and they recorded two cases with moderate hemorrhage following FB for whom intervention with argon plasma coagulation was required. Severe hemorrhage with hemodynamic instability that necessitated fluid replacement therapy, rigid bronchoscopic, or surgical intervention was not recorded in any patient among their study. No other complications or death were recorded. Ernst et al. [18] also confirmed the present results and recorded that biopsies performed with the cryoprobe proved extremely safe with no recorded bleeding complications because airway bleeding and mucosal tears may be avoided due to freezing times, thus limiting the depth and extension of tissue adherence to the cryoprobe. Aktas et al. [19] confirmed the present study and showed any advantage of CB compared with FB in reducing significant bleeding complications. On the other hand; Hamidreza et al. [16] found that CB was superior over FB in decreasing bleeding complications among the included patients. Schumann et al. [20] also supported the present results as they stated that the rate of bleeding of FB procedure is generally low. The bleeding rates vary from one major complication to 11 potentially life-threatening hemorrhages, representing an average bleeding rate of about 17% in FB. Using 'hot' biopsy by electrocoagulation assumed a reduced rate of bleeding without any worse impact on histopathologic sample results. In contrast, a 'cold' CB significantly increased the diagnostic yield with comparably low bleeding rates, which occurred in 5.1% of their included patients; most of them presented with mild bleeding (3.7%), followed by moderate bleeding in 1.0%, and severe bleeding occurred in only one (0.3%) case in a 78-year-old patient, supposing an affected tumor vessel, necessitating transfusion of one red blood cell concentrate and the patient fully recovered. So, the complication rate in the CB procedure was low. Regarding the epidemiological data of the included patients all were men (100%; n=40) with a mean age of 60.25±6.48 years, supporting the fact that the incidence of lung cancer is more in men than in women. These results came in accordance with Rivera et al. [1] and Maiwand and Asimakopoulos [21] studies who concluded that lung cancer incidence is still higher in men than in women. However, the magnitude of this difference has decreased, reflecting the fact that the incidence rate for women is almost stationary whereas the male incidence rate continues to decrease. Emerging evidence suspects that there are differences in the pathogenesis with increasing female susceptibility to lung cancer.
As regards histopathological examination for tissue biopsies in the present study, 35 (94.5%) patients were diagnosed as nonsmall cell lung cancer (NSCLC); 15 (40.5%) of them were diagnosed by conventional FB; and the other 20 (54.0%) were diagnosed by the CB technique. Among them, squamous cell carcinoma (SCC) had the highest incidence [20 (57.1%) patients were diagnosed as SCC]; nine (25.7%) were confirmed by conventional FB, whereas the remaining 11 (31.4%) by CB. Adenocarcinoma was the pathological type of the second incidence [15 (42.8%) patients]; six (17.1%) patients were diagnosed by conventional FB, whereas the remaining nine (25.7%) were confirmed by CB. No cases of large-cell carcinoma were detected. Small-cell lung cancer (SCLC) was the least pathological type of malignant lung masses in the present study; only two (5.5%) cases were diagnosed as SCLC and both of them were diagnosed by bronchoscopic FB. These results were convenient with those of Shi et al. [22] who stated that lung cancer classification is based on histological data. These tumors are divided into two main groups: SCLC that represents 15% of all lung cancer types and NSCLC which comprises the remaining 85% of lung cancer cases is further divided into: SCC, largecell carcinoma, and adenocarcinoma. These were also in agreement with those of Molina et al. [23] and Alberg et al. [24] who reported that NSCLC consists of 87% of lung cancers overall. This was not in accordance with Beasley et al. [25] who reported that adenocarcinomas account for about 40% of all types of lung cancers. SCC incidence is about 25-30%, whereas large-cell (undifferentiated) carcinomas represent about 10-15% of all lung cancers. They explained this by the fact that all histopathological subtypes of lung cancer may be present in atypical histologic forms and in several mixed cell-type combinations as well, referring that adenocarcinoma is the most common type of NSCLC. Zafer et al. [10] stated that even if with small tissue specimen, NSCLC and SCLC could be well differentiated without any confusion. In contrast to Zafer et al. [10] and in agreement with the present study results were those of Bilello et al. [26] who reported that improvement and accuracy for the histological diagnosis of NSCLC is markedly improved by the size and adequacy of the examined specimen. In their study, FB successfully confirmed NSCLC diagnosed among the included 14 patients. Only four patients of their included 14 were diagnosed similarly with combined CB and FB. On the other hand, epidermoid carcinoma was confirmed among nine of the included 14 patients, whereas adenocarcinoma was diagnosed in only one patient when CB and FB procedures were used in combination, which demonstrate that cryobiopsies are superior and had better diagnostic yield for proper differentiation due to superior morphological preservation in case of detailing NSCLC when compared with FB.
Conclusion
Endobronchial CB is a safe, successful, and confident technique with superior diagnostic yield compared with FB mainly because of the larger size and better quality of the obtained specimens' excellent tissue preservation than that used during conventional fiberoptic FB.
Recommendations
Further investigations and studies are required to determine the accuracy and efficacy of CB and a possible rationale for its use as a part of routine diagnostic bronchoscopy.
